Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: Final results from Fight-202 Meeting Abstract


Authors: Vogel, A.; Sahai, V.; Hollebecque, A.; Vaccaro, G. M.; Melisi, D.; Rajabi, R. M.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; Oh, D. Y.; Dotan, E.; Catenacci, D. V.; Van Cutsem, E.; Lihou, C. F.; Zhen, H.; Veronese, L.; Abou-Alfa, G. K.
Abstract Title: Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: Final results from Fight-202
Meeting Title: 2022 Annual Meeting of the British Association for the Study of the Liver (BASL)
Journal Title: Gut
Volume: 71
Issue: Suppl. 3
Meeting Dates: 2022 Sept 20-23
Meeting Location: Leeds, England
ISSN: 0017-5749
Publisher: BMJ Publishing Group Ltd.  
Date Published: 2022-09-01
Start Page: A44
Language: English
ACCESSION: WOS:000891079700070
DOI: 10.1136/gutjnl-2022-BASL.69
PROVIDER: wos
Notes: Meeting Abstract: P18 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa